Sarepta Therapeutics Inc (SRPT)

Days of sales outstanding (DSO)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Receivables turnover		3.08	4.28	4.59	5.33	4.19
DSO	days	118.32	85.26	79.56	68.49	87.10

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.08
= 118.32

The Days of Sales Outstanding (DSO) ratio measures how long it takes for a company to collect payments from its customers after making a sale. A higher DSO indicates that the company is taking longer to collect payments, which can impact its cash flow and liquidity.

Analyzing the DSO trend for Sarepta Therapeutics Inc over the past five years, we can see fluctuations in the metric:
- In 2023, the DSO is 118.32 days, significantly higher than in the previous year. This increase suggests that the company is taking longer to collect payments from customers, possibly indicating challenges in managing accounts receivable efficiently.
- In 2022, the DSO decreased to 85.26 days compared to the prior year, which could indicate an improvement in the company's collection process.
- In 2021, the DSO was 79.56 days, showing a slight decrease from the previous year, which could be seen as a positive sign for the company's cash flow management.
- In 2020, the DSO stood at 68.49 days, indicating a relatively efficient collection process compared to the following years.
- In 2019, the DSO was 87.10 days, higher than in 2020 but slightly lower than in 2023.

Overall, the fluctuating trend in DSO for Sarepta Therapeutics Inc suggests some variability in its accounts receivable management over the years. It would be essential for the company to closely monitor and potentially optimize its credit policies and collection efforts to ensure timely cash inflows and maintain financial health.